Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Zura Bio Ltd has a consensus price target of $16.44 based on the ratings of 10 analysts. The high is $26 issued by Piper Sandler on September 19, 2024. The low is $5 issued by HC Wainwright & Co. on December 24, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on December 24, 2024, November 18, 2024, and November 11, 2024, respectively. With an average price target of $5 between HC Wainwright & Co., there's an implied 170.27% upside for Zura Bio Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Zura Bio (NASDAQ:ZURA) was reported by HC Wainwright & Co. on December 24, 2024. The analyst firm set a price target for $5.00 expecting ZURA to rise to within 12 months (a possible 170.27% upside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for Zura Bio (NASDAQ:ZURA) was provided by HC Wainwright & Co., and Zura Bio reiterated their neutral rating.
There is no last upgrade for Zura Bio
There is no last downgrade for Zura Bio.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zura Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zura Bio was filed on December 24, 2024 so you should expect the next rating to be made available sometime around December 24, 2025.
While ratings are subjective and will change, the latest Zura Bio (ZURA) rating was a reiterated with a price target of $5.00 to $5.00. The current price Zura Bio (ZURA) is trading at is $1.85, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.